Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205. - Lukas RV; Zhai L; Lauing KL; Kim M; Koch T; Penco-Campillo M; Bommi P; Dixit K; Kumthekar P; Sharp L; Lezon R; Garcia D; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)